invitae corporation | Genetic testing: Invitae DNA testing for better

Keyword	CPC	PCC	Volume	Score	Length of keyword
invitae corporation	1.73	0.2	2193	53	19
invitae	0.68	0.9	7358	41	7
corporation	1.66	0.4	6862	39	11

Keyword	CPC	PCC	Volume	Score
invitae corporation	0.81	0.1	4274	35
invitae corporation stock	1.3	0.2	96	90
invitae corporation news	0.78	0.3	9201	16
invitae corporation san francisco	0.34	0.7	1078	84
invitae corporation nvta	1.06	0.3	3943	87
invitae corporation bankruptcy	0.85	0.9	7228	25
invitae corporation lab	0.68	0.3	9115	28
invitae corporation stock price	1.67	0.3	7796	4
invitae corporation 10k	1.83	0.9	6245	32
invitae corporation claims agent	0.17	0.3	1097	58
invitae corporation cost	1.09	0.1	6122	47
invitae corporation yahoo finance	0.87	0.5	9107	35
invitae corporation billing	0.33	0.7	398	75
invitae corporation seattle wa	1.2	0.4	1312	34
invitae corporation san francisco ca	0.1	0.2	6877	22
what is invitae corporation	0.71	0.4	5303	17

Search Results related to invitae corporation on Search Engine

Genetic testing: Invitae DNA testing for better health
invitae.com

https://www.invitae.com/

WebInvitae offers advanced genetic testing that can be easily integrated into medical practices. Improve patient care with actionable insights based on DNA.

DA: 90 PA: 91 MOZ Rank: 59

About Invitae: Our story, mission & corporate information
invitae.com

https://www.invitae.com/us/about

WebOur story. At Invitae, we believe that good health is possible—and that genetic information has the ability to transform the way medicine is practiced, making what once seemed impossible possible, as we empower people to make decisions about their health through the power of genetics.

DA: 8 PA: 57 MOZ Rank: 47

Invitae - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Invitae

WebInvitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion.

DA: 31 PA: 64 MOZ Rank: 76

Invitae - Invitae Publishes its Environmental, Social and …
invitae.com

https://ir.invitae.com/news-and-events/press-releases/press-release-details/2024/Invitae-Publishes-its-Environmental-Social-and-Governance-ESG-Report/default.aspx

Web3 days ago · Invitae (OTC: NVTA), a leading medical genetics company, today published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a holistic view of the company's approach to ESG and its performance and progress through measurable data and metrics during the 2023 fiscal year. "At Invitae, sustainability isn't …

DA: 6 PA: 34 MOZ Rank: 51

What we’re about | Invitae genetic tests
invitae.com

https://www.invitae.com/us/what-we-are-about

WebInvitae’s mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

DA: 64 PA: 41 MOZ Rank: 82

Medical genetic testing that experts trust - Invitae
invitae.com

https://www.invitae.com/us/providers

WebOur easy-to-order genetic test panels align with professional guidelines, making your potential next steps clearer. Plus, Invitae is in network with all national US health insurance plans. We also offer accessible self-pay pricing options. See how it works.

DA: 8 PA: 68 MOZ Rank: 16

Invitae - Invitae Announces Strategic Business Realignment to
invitae.com

https://ir.invitae.com/news-and-events/press-releases/press-release-details/2022/Invitae-Announces-Strategic-Business-Realignment-to-Accelerate-Its-Path-to-Positive-Cash-Flow-and-Realize-Full-Potential-of-Industry-Leading-Genetics-Testing-Platform/default.aspx

WebJul 18, 2022 · Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices.

DA: 57 PA: 65 MOZ Rank: 31

Invitae - IR HOME
invitae.com

https://ir.invitae.com/investor-relations/default.aspx

WebInvitae Unveils New Research for Breast Cancer Patients with Variants ... Read more. Invitae Launches Update to Invitae Generation™: Clinical Variant Model... Read more. Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 ... Read more.

DA: 3 PA: 31 MOZ Rank: 28

Invitae - Invitae Reports Fourth Quarter and Full Year 2022 …
invitae.com

https://ir.invitae.com/news-and-events/press-releases/press-release-details/2023/Invitae-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-Provides-Company-Updates/default.aspx

WebFeb 28, 2023 · Fourth quarter 2022 revenue of $122.5 million, versus $126.1 million a year ago, reflecting the impact of exited businesses and geographies announced earlier in the year. GAAP gross profit was $99.1 million in 2022, including $29.6 million in …

DA: 76 PA: 91 MOZ Rank: 51

Invitae - Invitae to Acquire Ciitizen to Strengthen its Patient
invitae.com

https://ir.invitae.com/news-and-events/press-releases/press-release-details/2021/Invitae-to-Acquire-Ciitizen-to-Strengthen-its-Patient-Consented-Health-Data-Platform-to-Improve-Personal-Outcomes-and-Global-Research/default.aspx

WebSep 7, 2021 · About Invitae. Invitae Corporation is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices.

DA: 52 PA: 97 MOZ Rank: 50